
Sign up to save your podcasts
Or
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will be available until January 20, 2026.
Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).
Disclosure information is available at the beginning of the video presentation.
3.5
2727 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will be available until January 20, 2026.
Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).
Disclosure information is available at the beginning of the video presentation.
129 Listeners
6 Listeners
3 Listeners
3 Listeners
10 Listeners
5 Listeners
9 Listeners
3 Listeners
2 Listeners
5 Listeners
3 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
1,867 Listeners
524 Listeners
2 Listeners
965 Listeners
10 Listeners
2 Listeners
487 Listeners
689 Listeners
270 Listeners
254 Listeners
3,318 Listeners
84 Listeners
1,090 Listeners
183 Listeners
512 Listeners
243 Listeners
362 Listeners